Everything you need to know about Accutane, including user reviews
Accutane (also known as isotretinoin), or Roaccutane as is also known in parts of the world, was discovered in 1979 when it was first given to patients with severe acne, most of whom reacted with dramatic and permanent clearing of their acne symptoms. It is a vitamin A derivative (13-cis-retinoic acid) which is administered orally in pill form, normally for 15-20 weeks (3.5-4.5 months).1 It was originally prescribed for people with severe acne that did not respond to other treatments,2 but has gained in popularity in the past 25 years and is prescribed more and more frequently for less severe acne.3-5 This practice is controversial because Accutane is a serious medication and causes side effects which can be as devastating as they are widespread. Accutane need not be paired with other medications.6
Exactly how Accutane works on a cellular level is unknown, but we do know that it affects all four ways that acne develops.
Although acne may get worse within the first month of Accutane use for about 30% of patients, the ultimate results are usually dramatic.10 Accutane works to achieve partial or complete clearance of acne in about 95% of people who complete a cycle, regardless of whether they have inflammatory or non-inflammatory acne.11 The majority of people who take it see their acne effectively cured, experiencing long-term remission of acne symptoms. Studies show an average relapse rate of around 33%, and in these cases sometimes a second course is given.6,8,11-15 This relapse rate is dose-dependent.12 Patients who receive a cumulative dose of 100-120 mg/kg see the best results and lowest relapse rates. Patients who receive a lower dose relapse more frequently. Daily dosage depends on how much the patient weighs; 0.5 mg - 2 mg/kg is typical.14
Low and intermittent dosing: Researchers have published two studies attempting to gauge whether people with mild to moderate acne can achieve long term remission of acne with lower dosages of Accutane. Initial data is showing that people with mild to moderate acne may be able to achieve long term remission with only about 75% of the usual Accutane dose, and thus suffer less side effects.16-17 Intermittent dosing (taking Accutane only 1 week of every month) appears to work less well, producing inadequate results for more than half of the patients studied.17
AKA Hepatotoxicity. Clinical research found this to occur in 15% of cases.3
AKA Pancreatitis. Clinical research found this to rarely occur.
Difficulty breathing (bronchospasms, respiratory infection, and voice alteration).8
Clinical research found this to occur in 92% of cases.3,8
AKA Xerosis. Clinical research found this to occur in 57% of cases.3,7-8
AKA Epistaxis. Clinical research found excessively dry nose to occur in 30% of cases.8
Eczema is a medical condition in which patches of skin become rough and inflamed, with blisters that cause itching and bleeding. Clinical research has shown it may be exacerbated by Accutane use.7-8 Other, more rare forms of facial rash have been reported.10
A small percentage of people are affected on a short-term basis and at a low level.7-8
Cheilitis.8
AKA Uticaria. Rare cases of allergic reaction to Accutane, including hives, have been reported.7-8
Alopecia is a condition that results in loss of hair from the scalp and sometimes other areas of the body. Rare cases have been reported.7
Rare cases of hirsutism have been reported.
Extremeley rare cases of nail abnormalities have been reported.
AKA Xanthomas. Clinical research found this to rarely occur.
Accutane is the #1 prescribed teratogenic (causes birth defects) medication in the United States.2
AKA Myalgia. Clinical research found this to occur in 15% to 50% of cases.7-8,14,19-20
Clinical research found this to occur in 30% of cases.
AKA Arthralgia. Clinical research found this to occur in 15% to 35% of cases.7-8,13-16
AKA hyperostosis. Clinical research found detectable changes to occur in 10% of cases.8,11
Inflammation of a tendon.7-8
Temporary yet painful inflammation and stiffness of the joints.8,15
Clinical research found this to occur extremely rarely.14,17-18
Calcification is hardening of the bone, tendon, or ligament caused by the deposition of or conversion into calcium carbonate or some other insoluble calcium compounds; calcified cartilage.11 Clinical research found this to occur only in high-dose, long-term (several years) Accutane therapy.12
AKA Rhabdomyolysis. Clinical research found this to occur in rare cases.8
Clinical research found this occurred in 10% to 28% of cases.8
Certain: abnormal oil secretion in the eye (abnormal meibomian gland secretion), inflamed mucus membrane that lines the eye (blepharoconjunctivitis), cornea becomes less transparent (corneal opacities), loss of night vision (decreased dark adaptation), decreased tolerance to contact lenses, decreased vision, increased salt concentration in tears (increased tear osmolarity), inflamed cornea (keratitis), oil gland atrophy in the eye (meibomian gland atrophy), near- or shortsightedness (myopia), eye discomfort (ocular discomfort), dry eye (ocular sicca), excessive sensitivity to light (photophobia), birth defects regarding the eyes (teratogenic ocular abnormalities).7,8
Probable/likely: decreased color vision [reversible], permanent loss of night vision AKA loss of dark adaptation.3,9
Possible: permanent dry eyes AKA keratoconjunctivitis sicca.7-8
As a side note, the FAA {United States Federal Aviation Administration} is considering more stringent rules regarding pilots who have been exposed to Accutane.9
AKA intracranial hypertension. Clinical research found this to occur very rarely.8
Neurological symptoms.
Including dizziness, drowsiness, insomnia, lethargy, malaise, nervousness, tingling/pricking/numbness (paresthesias), seizures, stroke, fainting (syncope), and weakness. Clinical research found this to occur in 16-29% of cases.8
Depression and suicide have been linked to Accutane in clinical research but as data mounts, it appears unlikely that depression is more commn in people as a result of taking Accutane. More research on the connection between suicide, depression and Accutane is needed. See the Suicide & Depression section for more detailed information on the topic.21-22
AKA Cerebral ischemia. Clinical research found this to be extremely rare.23
"Has been reported" and "may persist after therapy has been discontinued."8
Rare anaphylactic reactions have been reported in clinical research.8
AKA Neutropenia.26
Although Inflammatory bowel disease and chrohn's disease are often connected with Accutane, clinical research found no correlation. Clinical research did find a weak correlation between Accutane and ulcerative colitis.27-28
Elevated triglycerides, cholesterol, transaminase. Clinical research found this to occur in 44%, 31%, and 11% of cases respectively.8,24-25
AKA Agranulocytosis. Clinical research found this to be rare but life-threatening.
AKA Anemia.
AKA Thrombocytopenia.
Patients have reported depressive symptoms while taking Accutane since shortly after the drug became legal in 1982. Whether the drug caused these depressive feelings remains a subject of intense debate. There are, after all, millions of people taking the drug, and there are bound to be people experiencing depression amongst them. Despite the confusion around this topic, Roche Pharmaceuticals®, the makers of Accutane, added a warning to its label regarding suicide and depression in 1998.
Media coverage on the topic spiked in 2000 when Michigan Congressman Bart Stupak's son BJ committed suicide while on Accutane. Research began in earnest to determine whether there is a causal link between Accutane, suicide & depression.1-2
Quite a few studies have been conducted since. These have included large population-based cohort studies, retrospective analysis studies, and relative risk estimates, performed in the United States, the UK, and Canada.3-11 The first of these studies showed no conclusive evidence linking Accutane with depression or suicide.1-2 As the studies mounted, the data continued to show no evidence of a link.7-9,12 One study published in the New England Journal of Medicine found, "431 cases of depression, suicidal ideation, suicide attempts, or suicide in U.S. patients treated with isotretinoin," within a 10 year period. The article went on to note that the numbers listed do not exceed the U.S. suicide rate.13
If a researcher were to examine the evidence from 2000 until 2005, he or she would likely conclude that there is no evidence linking Accutane with suicide or depression.7-9 However, as is often the case, further analysis showed limitations to many of the studies.14-15 A general overview published in 2006 by the International Journal of Dermatology noted, "the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between isotretinoin and psychiatric adverse events."16
Then, in 2006, depression-related behavior was shown in mice injected with the drug. While animal studies often do not reflect human models, it was marginally intriguing.10 But even more provocative was a large cohort case-crossover study published in 2008 by the Journal of Clinical Psychiatry, which was the first controlled study to find a correlation between Accutane, suicide and depression, albeit relatively minor.11 Two recent studies, one small American study and one large Swedish study, again showed no connection.5-6
The preponderance of the evidence at this point is that Accutane does not appear to be linked with suicide and depression. However, to be safe, it is important for anyone taking Accutane to closely monitor their mental health while on the drug.1,4,17 If you find yourself feeling depressed or suicidal, seek help right away.
The birth defects caused by Accutane are devastating and life threatening. Birth defects include skull, ear, eye, facial, central nervous system, cardiovascular, thymus, parathyroid abnormalities, and death.3 Clinical research shows extremely high risk for birth defects in pregnant women.4 The effects and risks of Accutane on unborn children are so severe that female patients of childbearing age are required to use two (2) forms of birth control while on Accutane.5
The iPLEDGE program was launched in March 2006 to prevent women from becoming pregnant while on Accutane.5-6
iPLEDGE program telephone: 1-866-495-0654
iPLEDGE program website: ipledgeprogram.com
Roche started with a program called SMART (System to Manage Accutane Related Teratogenicity) in 2000, which became the iPLEDGE program in March, 2006. Female patients of childbearing age are required to use two (2) forms of birth control while on Accutane.
Gerald Peck and co-workers from the NIH (National Institutes of Health) in Bethesda, Maryland, first studied isotretinoin in patients with skin cell disorders. They accidentally found that it also worked on patients with severe acne. Isotretinoin was registered in 1979, released in the United States in 1982 as Accutane, and released in Europe in 1985 as Roaccutane.1
Roche's patent expired in 2002, and manufacturers began selling generic forms of the drug.
In June, 2009, shortly after a jury awarded $33 million in damages to people who claimed Accutane caused bowel disease, Roche decided to discontinue selling brand name Accutane. The company cited declining sales as their reason.
According to the FDA:
Buying Accutane or any other prescription over the Internet often means you will receive pills that contain little or no active ingredient, or in some cases, a different medication entirely. Buying Accutane over the Internet is not only illegal, it is potentially dangerous and is also a waste of money.4 I agree strongly with the FDA. NEVER buy Accutane over the Internet."
Dan Kern
Acne.org Founder
Topical isotretinoin exists but does not produce the results of oral isotretinoin. It is largely of historical significance in acne treatment.
As a critical sociology major in college, I learned that it is important for an author to present his or her bias. Because we are human and it is impossible to be completely unbiased, the presentation of bias allows the reader to take the author's bias into account when absorbing content.
My bias: I suffered with moderately severe acne in my adolescence and early adulthood. I took Accutane at age 20. It cleared me up completely within weeks. I transformed from a shy introvert to an outgoing college student. As a result of my skin clearing up, my mental state felt relatively light and good, albeit still somewhat anxious as I had always been. My side effects included severely dry lips, extremely dry skin, dry eyes and sometimes severe joint pain. Since Accutane, whenever I sprint or exert myself in quick bursts my joints react with inflammation. Whether this is coincidence or the result of Accutane is unclear. My acne relapsed post-Accutane, albeit not to the degree it was before my Accutane cycle. I am now able to control my acne symptoms with The Regimen."
Dan Kern
Acne.org Founder